000			03140nam a22003615i 4500
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
988			_aSpringer_Medicine_2018
999			_c343842 _d343842 _x1
001			343842
003			ES-MaUEC
005			20230102120147.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			180828s2018 gw | s |||| 0|eng d
020			_a9783319911106
024	7		_a10.1007/978-3-319-91110-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
050		4	_aRC685.M9 _b2018 EB
245	1	0	_aT1-Mapping in Myocardial Disease : _bPrinciples and Applications _cedited by Phillip C. Yang.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (X, 113 páginas) _b47 ilustraciones, 41 ilustraciones a color
490			_aMedicine (Springer-11650)
505	0		_aFundamentals of Cardiac T1 Mapping -- T1 Mapping in Cardiac Hypertrophy -- T1 mapping in cardiomyopathy from cancer treatment -- Comparison of T1 mapping by cardiac MRI to non-cardiac MRI methods to evaluate cardiac fibrosis -- T1 Mapping in Aortic Stenosis -- T1 Mapping in Peri-Infarct Injury in Ischemic Cardiomyopathy -- T1 mapping in stem cell therapy -- T1 Mapping in Uncommon Non-Ischemic Cardiomyopathies.
520			_aThis book details the advances in cardiac MRI that have enabled quantitative tissue characterization of the myocardium using myocardial and blood T1 measurements, which have enabled reliable detection of diffuse pathological processes in both the cardiomyocytes and the interstitial cells of the myocardium. Evaluation of the native myocardial and interstitial fibrosis, and measurement of the extracellular volume fraction has allowed an unprecedented opportunity to elucidate the pathology, diagnosis and prognosis of cardiovascular disease. T1-Mapping in Myocardial Disease: Principles and Applications reviews a wide spectrum of significant cardiovascular disease and provides relevant guidance for the clinical implementation of this innovative technique. The specific topics covered include principles of T1-mapping in cardiovascular disease and the role of T1-mapping in hypertensive heart disease and hypertrophic cardiomyopathy, cardiotoxicity from cancer treatment, cardiacfibrosis, left ventricular hypertrophy in aortic stenosis, peri-infarct injury in ischemic cardiomyopathy, and stem cell therapy. This comprehensive coverage of the utility of T1-mapping in cardiovascular diseases will greatly appeal to the entire cardiovascular medicine and imaging communities.
650		7	_2embne _9231884 _aMiocardio _xEnfermedades
700	1		_aYang, Phillip C. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783319911090
776	0	8	_iPrinted edition: _z9783319911113
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-91110-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _a_alco _a_vill _b02/2019 _cm _dz _feng _ggw _h0